Patient exposure | TH group (n=47) | Control group (n=47) | p Value |
BVD | 12 (26) | 2 (4) | 0.04 |
PICU care (n=22) and BVD, n (%) | 4 (18)* | 2 (9)* | 0.7 |
NICU care (n=25) and BVD, n (%) | 8 (32)* | 0 (0)* | 0.004 |
NG position abnormal or not documented on first day, n (%) | 5 (11) | 15 (32) | 0.06 |
NG abnormal and BVD, n (%) | 2 (14) | 1 (8) | 1.00 |
Opioid used at any point, n (%) | 40 (85) | 24 (51) | 0.0004 |
Opioid used and BVD, n (%) | 11 (28) | 1 (4) | 0.02 |
Muscle relaxant used at any time, n (%) | 11 (23) | 11 (23) | 1.00 |
Muscle relaxant use and BVD, n (%) | 3 (27) | 0 (0) | 0.2 |
Blood culture (n=45 TH, n=30 control) positive, n (%) | 3 (7) | 1 (3) | 0.5 |
Blood culture positive and BVD, n (%) | 0 (0) | 0 (0) | n/a |
*Comparison of proportion of patients with BVD between unit of care (PICU vs NICU) was not significant in either the TH (p=0.33) or control (p=0.21) groups.
BVD, bilious vomiting or drainage; NG, nasogastric; NICU, neonatal intensive care unit; PICU, paediatric intensive care unit; TH, therapeutic hypothermia.